11 June 2024 in Nature Communications
Missions into Deep Space are planned this decade. Yet the health consequences of exposure to microgravity and galactic cosmic radiation (GCR) over years-long missions on indispensable visceral organs such as the kidney are largely unexplored. We performed biomolecular (epigenomic, transcriptomic, proteomic, epiproteomic, metabolomic, metagenomic), clinical chemistry (electrolytes, endocrinology, biochemistry) and morphometry (histology, 3D imaging, miRNA-ISH, tissue weights) analyses using samples and datasets available from 11 spaceflight-exposed mouse and 5 human, 1 simulated microgravity rat and 4 simulated GCR-exposed mouse missions. We found that spaceflight induces: 1) renal transporter dephosphorylation which may indicate astronauts’ increased risk of nephrolithiasis is in part a primary renal phenomenon rather than solely a secondary consequence of bone loss; 2) remodelling of the nephron that results in expansion of distal convoluted tubule size but loss of overall tubule density; 3) renal damage and dysfunction when exposed to a Mars roundtrip dose-equivalent of simulated GCR.
11 June 2024 in Communications Biology
Organismal adaptations to spaceflight have been characterized at the molecular level in model organisms, including Drosophila and C. elegans. Here, we extend molecular work to energy metabolism and sex hormone signaling in mice and humans. We found spaceflight induced changes in insulin and estrogen signaling in rodents and humans. Murine changes were most prominent in the liver, where we observed inhibition of insulin and estrogen receptor signaling with concomitant hepatic insulin resistance and steatosis. Based on the metabolic demand, metabolic pathways mediated by insulin and estrogen vary among muscles, specifically between the soleus and extensor digitorum longus. In humans, spaceflight induced changes in insulin and estrogen related genes and pathways. Pathway analysis demonstrated spaceflight induced changes in insulin resistance, estrogen signaling, stress response, and viral infection. These data strongly suggest the need for further research on the metabolic and reproductive endocrinologic effects of space travel, if we are to become a successful interplanetary species.
4 January 2023 in Research Square
Organismal adaptations to spaceflight have been characterized at the molecular level in model organisms, including Drosophila and C. elegans. Here we extend molecular work to energy metabolism and sex hormone signaling in mice and humans. We found spaceflight-induced changes in insulin and estrogen signaling in rodents and humans. Murine changes were most prominent in the liver, where we observed inhibition of insulin and estrogen receptor signaling with concomitant hepatic insulin resistance and steatosis. Based on the metabolic demand, metabolic pathways mediated by insulin and estrogen vary among muscles, specifically between the soleus and extensor digitorum longus. In humans, spaceflight induced changes in insulin and estrogen related genes and pathways. Pathway analysis demonstrated spaceflight-induced changes in insulin resistance, estrogen signaling, stress response, and viral infection. These data strongly suggest the need for further research on the metabolic and reproductive endocrinologic effects of space travel, if we are to become a successful interplanetary species
26 August 2024 in Research Square
CO2 bubbles and pockets have plagued astronauts for many decades since the inception of space exploration, with recurrent reports from astronauts of headaches as the main symptom. The first CO2 monitors were deployed in the International Space Station (ISS) in 2001, and have reported average CO2 concentrations of ~ 0.5% (or 5000 ppm) in air. Despite the enhancement in performance of CO2 removal systems that extract CO2 from ISS cabins to the external environment, CO2 concentrations that are at least ~ 0.3% have prevailed, causing CO2-related symptoms and subclinical changes to physiology. In order to explain the abnormal concentrations of CO2 in the breathing environment of the astronauts, the authors suggest that there is a build-up of CO2 that is influenced by the lack of gravity, also termed microgravity, in low Earth orbit (LEO). This suggestion is motivated by the effect of gravity on buoyancy-driven convection that can facilitate the advection of exhaled CO2 from the breathing envelope of a respirator, preventing its build-up in the breathing envelope. The processes that define the behavior of CO2 in the breathing environment of a respirator in astronaut-like conditions in the ISS are revealed through simulations of a computational fluid dynamics (CFD) model of a human respirator that exercises breathing over several breath cycles. This modeling effort is unique among research efforts that have studied CO2 accumulation in the ISS crew habitat, as it accounts for all the main factors that influence the dynamics of CO2 – the transient nature of breathing, changes in thermodynamic variables in the environment, and, particularly, changes in CO2 dynamics over several breath cycles. While simulations of several breath cycles in normal gravity show no tendency for CO2 to accumulate in the breathing environment, accumulation of CO2 is evident in microgravity, with the inhalation of CO2 at average concentrations higher than 0.1% (1000 ppm) in air as a possible outcome in some breath cycles. Breathing in such an environment in a prolonged period of time lasting several days inevitably leads to the build-up of CO2-related illnesses.